Starlix


Novartis Medicare Resource Center
For U.S. Residents only
  Novartis Pharma US

 
Bookmark this page | E-mail this page | Print this page
 

Upcoming Events

AACE 15th Annual Meeting and Clinical Congress
April 26-30, 2006
Chicago, IL. Hyatt Regency Hotel


ADA 66th Annual Scientific Sessions
June 9-13, 2006
Washington, DC. Washington Convention Center


AADE 33rd Annual Meeting and Exhibition
August 9-12, 2006
Los Angeles, CA. LA Convention Center

Important Safety Information

The most common adverse events associated with Starlix vs. placebo were upper respiratory infection (10.5% vs. 8.1%), back pain (4.0% vs. 3.7%), flu symptoms (3.6% vs. 2.6%), dizziness (3.6% vs. 2.2%), hypoglycemia (2.4% vs. 0.4%), and arthropathy (3.3% vs. 2.2%).

Please see the full prescribing information.

 
See full prescribing information
 

Home  |  Mealtime Glucose Management  |  Mechanism of Disease
Mechanism of Action  |  Sample Case Studies  |  Relevant Articles
Financial Help for Those in Need  |  Important Product Information
For Consumers
Site Guide  |  Site Map  |  Contact Us

Novartis Pharma US Use of Web site is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access